Search by Drug Name or NDC

    NDC 13668-0086-05 OLANZAPINE 5 mg/1 Details

    OLANZAPINE 5 mg/1

    OLANZAPINE is a ORAL TABLET, ORALLY DISINTEGRATING in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Torrent Pharmaceuticals Limited. The primary component is OLANZAPINE.

    Product Information

    NDC 13668-0086
    Product ID 13668-086_ef53caaf-ca68-a0fc-e053-2a95a90ace16
    Associated GPIs 59157060007210
    GCN Sequence Number 045190
    GCN Sequence Number Description olanzapine TAB RAPDIS 5 MG ORAL
    HIC3 H7T
    HIC3 Description ANTIPSYCHOTIC,ATYPICAL,DOPAMINE,SEROTONIN ANTAGNST
    GCN 92007
    HICL Sequence Number 011814
    HICL Sequence Number Description OLANZAPINE
    Brand/Generic Generic
    Proprietary Name OLANZAPINE
    Proprietary Name Suffix n/a
    Non-Proprietary Name OLANZAPINE
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, ORALLY DISINTEGRATING
    Route ORAL
    Active Ingredient Strength 5
    Active Ingredient Units mg/1
    Substance Name OLANZAPINE
    Labeler Name Torrent Pharmaceuticals Limited
    Pharmaceutical Class Atypical Antipsychotic [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA091415
    Listing Certified Through 2024-12-31

    Package

    NDC 13668-0086-05 (13668008605)

    NDC Package Code 13668-086-05
    Billing NDC 13668008605
    Package 500 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (13668-086-05)
    Marketing Start Date 2011-10-25
    NDC Exclude Flag N
    Pricing Information N/A